Early clinical trials are conducted to establish initial safety of a drug. The studies are generally in small number of healthy subjects and use lower doses of the drug product. Therefore, only small amounts of investigational material are required. In order to not undertake substantial costs and to reduce regulatory burden during these early stages, the FDA has established guidelines to allow early stage investigational products to be manufactured under less stringent GMPs.
Course Objective:
To gain an understanding of the requirements for advancing drugs from research into early clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing phase I manufacturing strategies to meet FDA requirements. This webinar will provide the foundation and basis for advancing drugs into clinical development from research and providing required information to the FDA regarding these products. It will provide valuable guidance to provide the requirements for early stage products of different types and for vendor selection and management.
Course Outline:
• Moving a Product out of R&D
• CMC Requirements for an IND Study
• Good Manufacturing Practices: Basics for Beginners
• Raw Material Management
• GMPs for Phase 1 IND products
• GMPs for Combination Products and 505(b)(2) Products
• Process Validation for Early Stage GMP
• Outsourcing Early Stage Manufacturing
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Directors
• Manager
• Supervisors
• Lead workers in Regulatory Affairs Quality Assurance and Quality Control
• Workers who will prepare GMP documents for early phase products
• Workers who will review GMP documents for early phase products
• Regulatory affairs workers who will need to deal with submissions covering early phase products
Challenges for Data Collection in Clinical Trials for Low Cost Wearable Monitors
Get Instant Access 60 Minutes View Program |
Risk Based Clinical Trial Monitoring
Get Instant Access 75 Minutes View Program |
Clinical Trial Monitoring - Documentation and Closure
Get Instant Access 90 Minutes View Program |
Federalwide Assurances: What Are They? Why and When Do I Need Them?
Get Instant Access 60 Minutes View Program |
The Importance of Protocol Deviations and Violations to Subject Safety and Data Integrity will Surprise you
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry